The bacterium Salmonella enterica serovar Typhi causes typhoid fever, which is typically associated with fever and abdominal pain. An outbreak of typhoid fever in Malawi-Mozambique in 2009 was notable for a high proportion of neurologic illness.
Describe neurologic features complicating typhoid fever during an outbreak in Malawi-Mozambique
Persons meeting a clinical case definition were identified through surveillance, with laboratory confirmation of typhoid by antibody testing or blood/stool culture. We gathered demographic and clinical information, examined patients, and evaluated a subset of patients 11 months after onset. A sample of persons with and without neurologic signs was tested for vitamin B6 and B12 levels and urinary thiocyanate.
Between March – November 2009, 303 cases of typhoid fever were identified. Forty (13%) persons had objective neurologic findings, including 14 confirmed by culture/serology; 27 (68%) were hospitalized, and 5 (13%) died. Seventeen (43%) had a constellation of upper motor neuron findings, including hyperreflexia, spasticity, or sustained ankle clonus. Other neurologic features included ataxia (22, 55%), parkinsonism (8, 20%), and tremors (4, 10%). Brain MRI of 3 (ages 5, 7, and 18 years) demonstrated cerebral atrophy but no other abnormalities. Of 13 patients re-evaluated 11 months later, 11 recovered completely, and 2 had persistent hyperreflexia and ataxia. Vitamin B6 levels were markedly low in typhoid fever patients both with and without neurologic signs.
Neurologic signs may complicate typhoid fever, and the diagnosis should be considered in persons with acute febrile neurologic illness in endemic areas.
Citation: Sejvar J, Lutterloh E, Naiene J, Likaka A, Manda R, et al. (2012) Neurologic Manifestations Associated with an Outbreak of Typhoid Fever, Malawi - Mozambique, 2009: An Epidemiologic Investigation. PLoS ONE 7(12): e46099. doi:10.1371/journal.pone.0046099
Editor: Martyn Kirk, The Australian National University, Australia
Received: February 1, 2012; Accepted: August 28, 2012; Published: December 3, 2012
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: U.S. government funding, Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Typhoid fever is a bacterial disease caused by infection with Salmonella enterica serovar Typhi (Salmonella Typhi). It is transmitted through the fecal-oral route, generally by contaminated water or food. Typically, it presents as an acute febrile illness often accompanied by signs and symptoms such as headache, abdominal pain, diarrhea or constipation, and malaise . Other, more severe complications of typhoid fever include intestinal perforation, hepatitis, pneumonia, and tissue abscesses , . Neurologic illness has also been described, most frequently as acute encephalopathy or meningitis . A variety of objective neurologic signs have been documented, including acute neuropsychiatric illness , , , spasticity and clonus , , ataxia , , , , , , aphasia , , , and cerebritis , . However, these findings have generally appeared as case reports or small case series.
Beginning in June 2009, an outbreak of unexplained febrile illness occurred in villages along the border region between southern Malawi and western Mozambique. This area was known to have a high rate of general mild malnutrition, with most diets high in consumption of wheat, corn, and leafy vegetables. Cassava is consumed, but infrequently. Initial reports described many persons who presented with acute neurologic illness including mental status changes, headache, “difficulty walking”, dysarthria, and hyperreflexia. Other neurologic features including seizures and neck stiffness were also described. Gastrointestinal complaints were not prominent among patients early in the outbreak. The investigators initially suspected common etiologies of such neurologic abnormalities in sub-Saharan Africa such as acute encephalitis or heavy metal toxicity, as well as less common etiologies such as neurolathyrism and konzo. However, subsequent investigation revealed the outbreak to be caused by typhoid fever, and after the etiology was determined, persons with signs and symptoms more typical of typhoid fever were increasingly recognized.
We describe the results of an investigation into the clinical, neurologic and laboratory features of persons with typhoid fever during this outbreak. Our investigation suggests that signs of upper motor neuron dysfunction were predominant, neurologic features were generally a later manifestation of typhoid fever, and outcome was generally favorable.
The outbreak was first noted in June 2009 by health personnel in Neno District, Malawi, who observed an increase in patients hospitalized at Neno District Hospital with fever and neurologic illness. Ill patients were from villages in Neno District and neighboring Tsangano District, Mozambique. The outbreak occurred in a remote location; the closest health center, Nsambe Health Centre, is approximately 8.5 km away by dirt road over rough terrain. As cases continued, a larger investigation was initiated by the Malawi Ministry of Health (MOH).
Between July and November, 2009, an epidemiologic investigation was conducted  that included structured retrospective interviews of previously ill individuals to determine initial signs and symptoms, risk factors, and possible exposures; retrospective hospital record review; structured interview and clinical examination of acutely ill individuals; and verbal autopsy for deceased patients. Questions included specific assessment of dietary habits, sources of drinking water, and other possible exposures that might lead to an infectious or toxic etiology or result in a nutritional deficiency, Based upon initial clinical findings and laboratory results among outbreak patients, a case definition was established for suspected, probable, and confirmed cases  (Figure 1). Active surveillance was implemented in affected villages to identify possible patients presenting early in the course of illness.
We identified patients with neurologic illness by several methods. We reviewed medical records at Neno District Hospital for admissions during March through November 2009 for descriptions of objective neurologic findings. From July 22 through November 13, 2009, we prospectively gathered data on persons presenting with illness, and hospitalized patients meeting the case definition underwent neurologic evaluation by one of the authors, a U.S. board-certified neurologist (JJS). When possible, suspected patients meeting clinical case criteria but not hospitalized were evaluated in their villages. When possible, hospitalized patients were serially re-evaluated in order to document progression of illness; a subset of patients underwent re-evaluation approximately 11 months after acute illness to detect the presence of long-term neurologic sequelae.
Cerebrospinal fluid (CSF) white blood cell count (WBC), glucose, and protein level results were reviewed when available. Clinical specimens obtained from acutely ill patients, including serum, blood, urine, and CSF, initially underwent testing for a number of infectious agents including various viruses, bacteria, parasites, and rickettsiae, as well as various toxins at laboratories at CDC (Table S1). Typhoid-specific testing in the field was performed using a rapid diagnostic assay (TUBEX® TF, IDL Biotech, Bromma, Sweden) that detects IgM antibodies against the O9 lipopolysaccharide antigen of Salmonella Typhi. Following the establishment of field capacity to collect and transport specimens for culture, confirmatory testing for typhoid was performed by blood or stool culture.
Because some of the neurologic features observed in the patients were similar to those seen in some micronutrient abnormalities, we tested serum specimens on a subset of patients with and without neurologic illness for vitamin B6 and B12 concentrations. Serum B12 concentrations were assessed by electrochemiluminescence immunoassay (ECLIA; Roche Diagnostics Modular Analytics E170) at CDC. Serum B6 concentrations [pyridoxal 5′-phosphate (PLP) and 4-pyridoxic acid (4PA)] were assessed by high-performance liquid chromatography with fluorometric detection . PLP is indicative of longer-term vitamin B6 status, while 4PA is indicative of short-term vitamin B6 intake. Since the neurologic presentation including spasticity and clonus appeared similar to konzo, an illness due to cyanogen toxicity from consumption of improperly cooked bitter cassava, we also tested urine specimens from a subset of patients with and without neurologic illness for urinary thiocyanate levels, a marker for cyanogenic compound exposure. Urine thiocyanate was quantified using isotope dilution tandem mass spectrometry at CDC .
Three patients with neurologic illness underwent brain and spinal cord magnetic resonance imaging (MRI) at the Malawi MRI Facility in Blantyre. Autopsy was performed on one decedent with neurologic illness; tissue from central nervous system, meninges, lung, spleen, kidney, and liver was assessed by routine histology at University of Malawi Medical School, and immunohistochemical staining for leptospira and flaviviruses at CDC.
Data were entered into an Access™ database. Mean and median concentrations of vitamins B6 and B12 and urinary thiocyanate were calculated; comparisons between patients with and without neurologic illness were made using Wilcoxon rank-sum analysis. SAS software version 9.2 (SAS Institute Inc, Cary, NC) was used for analyses.
Determination of Possible Subclinical Community Neurologic Findings
To determine the possible presence of subclinical or mildly clinical upper motor neuron findings among village populations, persons in two affected villages, who were approximately representative of age group and sex distribution of typhoid cases were evaluated for the presence of objective neurologic findings during two village-wide evaluations. These persons underwent a screening neurological evaluation by one of the authors (JJS).
The Malawi MOH conducted the investigation in the context of an outbreak response and a public health intervention, and it was determined by human subjects review at CDC to be public health response evaluation and not research. Verbal consent was obtained from patients or guardians for collection of biological specimens and physical examination.
Between March 1 and November 13, 2009, we identified 303 persons meeting the case definition for typhoid fever, including 212 suspected, 45 probable, and 46 confirmed cases. Of these, 40 (13%) persons had objective, focal neurologic findings documented in the medical chart (n = 6) or elicited on examination (n = 34); an additional 27 persons had encephalopathy or altered mental status but did not demonstrate focal neurologic findings and were not included in subsequent analysis. Twenty-six of the 40 cases with neurologic signs met criteria for a suspected case, 10 for a probable case, and 4 for a confirmed case. The median age was 18 years (range: 3–57 years); 53% were female. Age and sex distribution were not significantly different between patients with and without neurologic illness (data not shown). Twenty-seven persons (68%) with neurologic illness were hospitalized, and there were five (13%) deaths; one decedent underwent autopsy. Twenty-one (53%) persons were treated with a variety of antimicrobials at some point during their illness, generally upon hospital admission. The most commonly administered antimicrobials included chloramphenicol (n = 15), lumefantrine-artemether (n = 9), and penicillin G (n = 7). Specific information on dose and duration of antimicrobial therapy was not available.
Neurologic signs among cases are shown in Table 1. Ascertainment of exact dates of onset of illness was difficult in this population; however, the mean interval between the best estimate of onset of illness and first documentation of neurologic signs (generally obtained at time of presentation) was 12.4 days (range, 1–35 days). The most common neurologic manifestations were upper motor neuron signs including deep tendon hyperreflexia, spasticity, and sustained ankle clonus; 17 patients had a constellation of all three of these signs. The lower extremities were most frequently affected, and spasticity frequently resulted in gait disturbance. Babinski's signs were present in five patients with other upper motor neuron features; bowel or bladder dysfunction was generally absent. Significant sensory abnormalities, including decrease of vibratory and position sense, were not observed. Twenty patients demonstrated truncal or appendicular ataxia or both, which also resulted in gait abnormalities. Ataxia was unaccompanied by cerebellar signs such as nystagmus or intention tremor. Eight patients demonstrated moderate to severe features of parkinsonism, including bradykinesia, postural instability, facial masking, and decreased arm swing. Other commonly observed neurologic features included flaccid dysarthria with hypophonetic speech (n = 21) and static/kinetic tremor (n = 4). In addition to neurologic signs, many patients described subjective neurologic symptoms including hearing loss and visual problems.
Eleven patients had CSF examination; WBC, protein, and glucose levels were within normal limits in all. No routine blood laboratory parameters were consistently abnormal among patients. Extensive diagnostic testing for other viral, bacterial, parasitic, and rickettsial pathogens, including broad-spectrum polymerase-chain reaction (PCR) testing and random-primer sequencing, was performed on 16 of the 303 patients overall and included four patients with neurologic illness. Viral cultures, serologic assays for infectious agents, and PCR for pathogen-specific nucleic acid sequences were negative, and random-primer PCR assays in serum were unremarkable or nonspecific. Autopsy specimens from one decedent with focal neurologic findings, including ataxia, spasticity, and clonus, showed patchy necrosis in the liver; histopathology of cerebral cortex, cerebellum, pons, and medulla were unremarkable and without perivascular cuffing or other signs of acute inflammation. Immunohistochemical assays for leptospira and flaviviruses in all tissues were negative.
Dietary Findings and Laboratory Results
Although chronic malnutrition was present in this poor and rural area, there had been no acute changes in food availability or food type consumption reported by villagers. Cassava consumption was reported in all affected areas, including both bitter and sweet cultivars, but no recent changes in cassava processing were reported. We were unable to elicit a history of pea or legume consumption, or other plants that would be suggestive of Lathyrus sativus. Serum vitamin B12 concentrations were assessed in 13 patients with and 10 patients without neurologic signs. The distribution of the 23 levels (range: 175–1540 pg/mL) was mainly within the central 95 percent reference interval generated from a sample of presumably healthy U.S. residents, and the distributions of the two groups were not significantly different from each other (Table 2). Only one patient (without neurologic signs) had a serum vitamin B12 concentration <200 pg/mL, a cutoff value often used to indicate B12 deficiency . Serum PLP and 4-PA concentrations were assessed in eight persons with and nine without neurologic illness. The distribution of these 17 PLP concentrations (range: 0.7–60.4 nmol/L) was lower than the central 95 percent reference interval generated from a U.S. population , while the 4PA concentrations (range: 7.4–456 nmo/L) were mainly within this referent range. Fourteen (82%) of the samples had low PLP values (<20 nmol/L) indicative of B6 deficiency, a higher percentage than that seen in the U.S. population (25% of non-supplement users) . The PLP and 4PA concentrations in the two groups were characterized by a large variance, making it difficult to assess statistical differences. However, the group with neurologic signs did not appear to have lower PLP and 4PA values than the group without neurologic signs. Urinary thiocyanate levels among 16 persons without neurologic illness were significantly higher than in 5 persons with neurologic illness (p = 0.004, Table 2); however, concentrations in all but one (without neurologic signs) were within the established reference range , and no urinary thiocyanate concentrations were above those previously associated with health effects .
MRI of the brain and spinal cord was performed on three symptomatic persons (two probable, one suspect) with neurologic signs including spasticity, ataxia, and parkinsonism, during their acute illnesses. No signal abnormalities were present, however all three demonstrated generalized cerebral atrophy disproportionate to age (5, 7, and 18 years) (Figure 2).
Coronal T1 FLAIR (A) and axial T2 FLAIR (B) MRI Images demonstrating generalized cerebral atrophy, 7 year-old male with neurologic illness associated with acute typhoid fever, Malawi.
Seventeen typhoid fever patients hospitalized with neurologic illness were serially evaluated for at least 1 week following onset. All had upper motor neuron signs in combination with other neurologic features; seven had parkinsonism. By 1 month after onset, seven had normal neurologic examinations and were symptomatically well with complete resolution of neurologic signs. By 2 months, an additional 6 had resolution of neurologic signs (Table 3). Four continued to display objective neurologic findings—an 18-year-old male with persistent myoclonus, ataxia, and spasticity; a 14-year-old female with persistent ataxia and parkinsonism; and a 7-year-old male and 16-year-old female both of whom had persistent lower extremity hyperreflexia, clonus, and spastic gait. Thirteen of these patients were re-assessed at approximately 11 months after acute illness; none had experienced a recurrence of neurologic illness, but the two patients with hyperreflexia, clonus, and spasticity at one month continued to demonstrate these signs.
Assessment of Subclinical Neurological Illness Among Unaffected Villages
Sixty-five persons from two affected villages who were without a history of illness compatible with typhoid within the previous 6 months, and did not describe a prior history of possible neurologic illness, underwent screening neurologic examination, 35 from Dackson, Mozambique, and 30 from Nseula, Malawi. Median age of these persons was 16 years (range, 4–78 years), and 54% were female, which was similar to the age and sex distribution of patients with neurologic illness (data not shown). Three (5%) persons (median age, 19 years) had brisk deep tendon reflexes with crossed adductors; 1 of these had sustained (>5 beats) ankle clonus. No history of prior neurologic illness could be elicited from these persons. Other nonspecific findings, including physiologic tremors and lower extremity areflexia, were observed in 9 persons.
This outbreak of typhoid fever in an area along the Malawi- Mozambique border was associated with a range of objective neurologic findings. Although neurologic complications of typhoid fever have been previously described, the prominence of neurologic illness early in the outbreak initially led to diagnostic confusion and caused investigators to consider numerous other etiologies thought more likely to result in acute febrile neurologic illness. Our investigation benefitted from detailed clinical information, extensive testing for other possible etiologies of neurologic illness, and laboratory confirmation of a large number of temporally and spatially clustered cases.
Thirteen percent of the 303 persons meeting case definition criteria for typhoid fever in this outbreak demonstrated objective neurologic illness. Neurologic signs have been previously described in association with typhoid fever, and have commonly included spasticity and clonus, ataxia, and dysarthria, and less frequently, neuropsychiatric features , , , cerebellar dysfunction , and ophthalmoplegia or other cranial nerve abnormalities , , . However, most descriptions of neurologic complications of typhoid fever have been from case reports or small case series, and laboratory confirmation of acute typhoid fever is often absent. To our knowledge, this is the first description of prominent neurologic findings associated with typhoid fever in an outbreak setting. Because outbreaks often result in persons with similar environmental exposures, and, in some cases, genetic factors, being affected, the relatively large number of persons presenting with neurologic illness in this setting may be of etiologic significance.
The most common manifestations in our patients were related to upper motor neuron dysfunction, including spasticity, clonus, and hyperreflexia; a bradykinetic–rigid syndrome; and ataxia. Other manifestations, including seizures, tremors, and dysarthria, were also observed. The presence of variable neurologic manifestations suggests that typhoid produces dysfunction at numerous sites within the nervous system. Many patients presented with neurologic findings in the absence of encephalopathy or other alteration in mental status, indicating that typhoid may produce focal, as well as generalized, neurologic dysfunction. With few exceptions, the neurologic findings in these subjects resolved over time, sometimes within weeks of acute illness, and long-term or recurrent neurologic sequelae were largely absent among a subset of persons we were able to assess in extended follow-up. Notably, we did not observe some of the other neurologic manifestations that have been frequently mentioned in the setting of typhoid fever, such as acute psychosis , , acute inflammatory polyradiculoneuropathy , , or focal cortical signs , , .
The reason for the high proportion of cases with neurologic illness during this outbreak is unclear, but there are several possibilities. Surveillance bias is possible; early surveillance and case detection efforts focused on those persons hospitalized with neurologic features. Following recognition of typhoid as the cause of the outbreak, more persons with features typical of typhoid fever, including abdominal pain and other gastrointestinal symptoms, were detected. The involvement of neurologists in the outbreak investigation possibly led to detection of neurologic features that might not be typically assessed or noted by other clinicians. Neurologic manifestations of typhoid have been described as a late manifestation of illness , , , and the median interval between symptom onset and documentation of neurologic signs in our patients was 12 days. Several factors, including delayed presentation to clinical care and ineffective antimicrobial treatment early in the outbreak because of multi-drug resistance of the causative Salmonella Typhi strain  may have led to a prolonged course of illness early in the outbreak, resulting in a greater prevalence of neurologic signs. Importantly, following implementation of early diagnostic capabilities and appropriate definitive antimicrobial treatment of typhoid fever with ciprofloxacin, the number of persons presenting with neurologic illness appeared to decrease, suggesting that prompt treatment may avert the onset of neurologic illness.
The mechanism by which typhoid fever may produce neurologic illness is unknown. Rare cases of Salmonella Typhi bacterial meningitis, meningo-encephalitis, and intracranial abscesses have been reported both in children and adults , , . However, a neuroinvasive bacterial process appears unlikely in our patients; CSF was generally unremarkable and without pleocytosis or protein elevation, features of meningismus were generally absent, and CNS tissue from one confirmed case with neurologic illness, as well as brain and spinal cord MRI on 3 acutely ill patients, did not demonstrate signs of inflammation. This is consistent with prior reports in which neurologic manifestations have largely been unassociated with evidence of CNS inflammation. For these same reasons, a para- or post-infectious immune-mediated inflammatory process in the majority of cases would seem unlikely.
An underlying host factor or environmental exposure that may predispose persons to develop neurologic illness in the setting of severe systemic infection due to typhoid is possible. Many of the predominant signs and symptoms observed in these patients, including spasticity, clonus, hyperreflexia, and ataxia, may be seen with micronutrient abnormalities including vitamin B6 toxicity/deficiency and B12 deficiency , , , . We assessed these micronutrient levels in a subset of persons with and without neurologic signs and did not detect significant differences; however, our sample size was small and variability in the data made it difficult to assess statistical differences. The upper motor neuron findings in this population initially appeared similar to konzo, a neurologic illness seen in tropical areas and associated with thiocyanate toxicity due to consumption of inadequately cooked bitter cassava , , . The ataxia demonstrated by some of our patients resembled tropical ataxic neuropathy, also related to the dietary use of large quantities of cassava over long periods of time , . Although we considered these etiologies because cassava was part of the local diet, the often dramatic and complete resolution of neurologic signs in our patients is inconsistent with konzo or tropical ataxic neuropathy, and measurement of urinary thiocyanate levels did not demonstrate evidence of acute or chronic cyanogen toxicity. Similarly, neurolathyrism seemed unlikely due to improvement in neurologic signs, and we could not obtain a history of consumption of peas or legumes , .
Production of a bacterial toxin may lead to neurologic illness, with toxins produced by Clostridium botulinum and Corynebacterium diphtheriae being fundamental examples . The diffuse nature of neurologic involvement observed with typhoid-associated disease, and the apparent reversibility of these signs may be suggestive of a bacterial toxic etiology. Salmonella Typhi produces a cytolethal toxin, but the role of this toxin in the pathogenesis of typhoid fever is unknown , . Isolates of Salmonella Typhi obtained from cases in this outbreak, including persons with neurologic illness, did not demonstrate significant differences in genetic or bacteriologic properties from other isolates in central Africa ; further investigations into the possible presence of a Salmonella Typhi-produced neurotoxin are ongoing. Some viral and bacterial infections have been proposed to result in a “cytokinemia” in which hyper-reactive pro- and anti-inflammatory cytokines result in alterations of CNS function with encephalopathy and neurologic illness , , . While our investigation did not include assessments of cytokine function, such an indirect effect of Salmonella Typhi on the nervous system should be explored in future studies.
Our study has limitations. We did not perform neurologic examinations on all outbreak patients, and the number of cases of neurologic illness may have been underestimated or otherwise biased. Not all patients with suspected illness were positive for or underwent testing for Salmonella Typhi infection, and misclassification of some cases is possible. While we initially screened a large number of cases for numerous other infectious and toxic etiologies of neurologic illness, other alternative or concomitant causes of febrile neurologic illness in these persons cannot be entirely excluded. HIV, which could certainly be a contributory factor in neurologic illness occurring in this population, was not routinely tested for. Baseline neurologic status on these patients was unknown, and some may have demonstrated neurologic findings unrelated to their typhoid illness. Specifically, the presence of disproportionate cerebral atrophy on MRI in 3 cases suggests that other host factors, such as nutritional deficiencies, prior cerebral infections, antenatal/perinatal insults, or other factors may result in a background level of mild neurologic illness in this population. It is possible that severe systemic illness caused by typhoid fever, or a Salmonella Typhi-specific factor, may exacerbate mild or subclinical neurologic deficits.
Our study demonstrates that persons with typhoid fever may develop acute and severe neurologic illness. The underlying pathophysiological mechanisms producing these features remain unknown. The varying neurologic manifestations observed in this group of patients with typhoid-associated neurologic illness suggest involvement of multiple nervous system localizations. Neurologic illness associated with typhoid fever appears to resolve over time, with few ongoing sequelae, a feature that is important in the prognostic assessment of cases. Acute infection with Salmonella Typhi should be included in the differential diagnosis of persons originating or traveling from a typhoid-endemic area with acute febrile neurologic illness, particularly if viral and bacterial etiologies more typically associated with neurologic illness are not apparent. A better understanding of the underlying pathophysiologic mechanisms associated with neurologic illness in typhoid fever is needed.
Initial pathogen testing among ill persons during outbreak of typhoid fever, Malawi – Mozambique, 2009
18-year old female with typhoid-associated neurologic illness demonstrating severe truncal and appendicular ataxia and facial masking.
The authors would like to thank the following individuals for their valuable contributions to this manuscript: Malawi Ministry of Health: Secretary Chris Kang'ombe, Ben Chilima, Kundai Moyo, and Kapangaza Ntonya; the Neno District Rapid Response Team; Partners in Health: Keith Joseph and Annemarie Ackerman; World Health Organization: F. R. Zawaira, Kelias Msyamboza, and Reggis Kasande; Population Services International; United Nations International Children's Fund; United States Agency for International Development; CDC-Malawi: Dr. Thomas Warne, Rankin Thamanda, Laston Thamangira, Victor Samidu, Ethel Mpagaja, CDC-Mozambique: Amy DuBois, Lisa Nelson; CDC-Nutritional Biomarkers Branch: Christine Pfeiffer, Michael Ryback, Usha Mandava, Huiping Chen, Donna LaVoie, Usha Mandava, Christine Pfeiffer, Daniel Rabinowitz, Michael Rybak, Rosemary Schleicher, Mary Xu, Mindy Zhang; CDC-DASH Laboratory: Nicole Burcher, Michael Dillon; CDC-NCEH Laboratory: Charles Dodson; CDC-Global Disease Detection: Ray Arthur, Rohit Chitale, Kira Christian; CDC-NCEZID: Cheryl Bopp, Michele Parsons, Ermias Belay, Katie Schilling, Sherif Zaki, Wun-Ju Shieh; CDC-NCIRD: Lauren Stockman; and the CDC Emergency Operations Center staff.
The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the U.S. Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry.
Conceived and designed the experiments: J. Sejvar EL SM J. Schier B. Barr MH GA. Performed the experiments: J. Sevjar EL JN AL RM SM SL LC KD DT YR J. Schier B. Barr SK B. Blount MH. Analyzed the data: J. Sejvar EL BN J. Schier MH GA EM. Contributed reagents/materials/analysis tools: BN SK B. Blount MH DT GA EM. Wrote the paper: J. Sejvar EL JN AL RM BN SM TK SL LC KD DT YR J. Schier B. Barr AD MM SK B. Blount MH DT EM.
- 1. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ (2002) Typhoid fever. N Engl J Med 347: 1770–1782. doi: 10.1056/nejmra020201
- 2. Crum NF (2003) Current trends in typhoid Fever. Curr Gastroenterol Rep 5: 279–286. doi: 10.1007/s11894-003-0064-0
- 3. Rajeshwari K, Yadav S, Puri RK, Khanijo CM, Sethi Y (1995) Cerebritis in typhoid fever. Indian Pediatr 32: 1305–1307.
- 4. Osuntokun BO, Bademosi O, Ogunremi K, Wright SG (1972) Neuropsychiatric manifestations of typhoid fever in 959 patients. Arch Neurol 27: 7–13. doi: 10.1001/archneur.1972.00490130009002
- 5. Venkatesh S, Grell GA (1989) Neuropsychiatric manifestations of typhoid fever. West Indian Med J 38: 137–141.
- 6. Psychiatric symptoms in typhoid fever. Br Med J 2: 436–437. doi: 10.1136/bmj.2.5864.436
- 7. Osuntokun BO, Adeuja AO, Bademosi O (1974) The prognosis of motor neuron disease in Nigerian africans. A prospective study of 92 patients. Brain 97: 385–394. doi: 10.1093/brain/97.1.385
- 8. Sachdev HS, Puri MP, Mohan M (1982) Acute cerebellar ataxia in typhoid fever. Indian Pediatr 19: 639–640.
- 9. Sawhney IM, Prabhakar S, Dhand UK, Chopra JS (1986) Acute cerebellar ataxia in enteric fever. Trans R Soc Trop Med Hyg 80: 85–86. doi: 10.1016/0035-9203(86)90202-6
- 10. Chand G, Singh K (1988) Acute cerebellar ataxia–a rare complication of enteric fever. J Assoc Physicians India 36: 741.
- 11. Cheong BM (2008) Typhoid fever presenting as acute cerebellar ataxia and severe thrombocytopenia. Med J Malaysia 63: 77–78.
- 12. David CB, Tolaymat A (1978) Typhoid fever: unusual presentation. J Pediatr 93: 533. doi: 10.1016/s0022-3476(78)81192-5
- 13. Dewan P, Pooniya V, Kaushik JS, Gomber S, Singhal S (2009) Isolated cerebellar ataxia: an early neurological complication of enteric fever. Ann Trop Paediatr 29: 217–219. doi: 10.1179/027249309x12467994693978
- 14. Singh S, Gupta A, Marwaha RK (1993) Wenckebach phenomenon and motor aphasia in enteric fever. Indian J Pediatr 60: 147–149. doi: 10.1007/bf02860525
- 15. Adehossi E, Parola P, Brouqui P (2003) Febrile Broca's aphasia: a rare presentation of typhoid fever. J Travel Med 10: 192–193. doi: 10.2310/7060.2003.35773
- 16. Bansal AS, Venkatesh S, Jones SR, Williams W (1995) Acute aphasia complicating typhoid fever in an adult. J Trop Med Hyg 98: 392–394.
- 17. Misra GC, Singh SP, Mohapatra MK, Mohapatra RK, Prusty PK, et al. (1985) Typhoid cerebellitis. J Indian Med Assoc 83: 352–353.
- 18. Lutterloh E, Likaka A, Sejvar J, Manda R, Naiene J, et al. (2012) Multidrug-resistant typhoid fever with neurologic findings on the Malawi-Mozambique border. Clin Infect Dis 54: 1100–1106. doi: 10.1093/cid/cis012
- 19. Rybak ME, Pfeiffer CM (2004) Clinical analysis of vitamin B(6): determination of pyridoxal 5′-phosphate and 4-pyridoxic acid in human serum by reversed-phase high-performance liquid chromatography with chlorite postcolumn derivatization. Anal Biochem 333: 336–344. doi: 10.1016/j.ab.2004.06.036
- 20. Valentin-Blasini L, Blount BC, Delinsky A (2007) Quantification of iodide and sodium-iodide symporter inhibitors in human urine using ion chromatography tandem mass spectrometry. J Chromatogr A 1155: 40–46. doi: 10.1016/j.chroma.2007.04.014
- 21. Thorpe SJ, Heath A, Blackmore S, Lee A, Hamilton M, et al. (2007) International Standard for serum vitamin B(12) and serum folate: international collaborative study to evaluate a batch of lyophilised serum for B(12) and folate content. Clin Chem Lab Med 45: 380–386. doi: 10.1515/cclm.2007.072
- 22. Morris MS, Picciano MF, Jacques PF, Selhub J (2008) Plasma pyridoxal 5′-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003–2004. Am J Clin Nutr 87: 1446–1454.
- 23. Blount BC, Pirkle JL, Osterloh JD, Valentin-Blasini L, Caldwell KL (2006) Urinary perchlorate and thyroid hormone levels in adolescent and adult men and women living in the United States. Environ Health Perspect 114: 1865–1871. doi: 10.1289/ehp.9466
- 24. Cliff J, Nicala D, Saute F, Givragy R, Azambuja G, et al. (1999) Ankle clonus and thiocyanate, linamarin, and inorganic sulphate excretion in school children in communities with Konzo, Mozambique. J Trop Pediatr 45: 139–142. doi: 10.1093/tropej/45.3.139
- 25. Khosla SN, Srivastava SC, Gupta S (1977) Neuro-psychiatric manifestations of typhoid. J Trop Med Hyg 80: 95–98.
- 26. Ali G, Rashid S, Kamli MA, Shah PA, Allaqaband GQ (1997) Spectrum of neuropsychiatric complications in 791 cases of typhoid fever. Trop Med Int Health 2: 314–318. doi: 10.1111/j.1365-3156.1997.tb00145.x
- 27. Ghosh JB (1995) Pharyngeal palsy in enteric fever. Indian J Pediatr 62: 627–628. doi: 10.1007/bf02761897
- 28. Kamala CS, Manimegalai S, Kumar S (1991) Palatal paralysis in enteric fever. Indian Pediatr 28: 1213–1214.
- 29. Nahata MC (1961) Ophthalmoplegia following enteric fever. J Indian Med Assoc 37: 134–135.
- 30. Ozen H, Cemeroglu P, Ecevit Z, Secmeer G, Kanra G (1993) Unusual neurologic complications of typhoid fever (aphasia, mononeuritis multiplex, and Guillain-Barre syndrome): a report of two cases. Turk J Pediatr 35: 141–144.
- 31. Chikanza IC, Latif AS, Neill P, Mason P, Olweny CL (1986) Unusual complications of typhoid fever. Cent Afr J Med 32: 31–34.
- 32. Kanwar K (1962) Symptomatology and treatment of typhoid paratyphoid fevers with special reference to the neurologic manifestations and liver damage. Indian J Child Health 11: 525–539.
- 33. Suri S, Bhasin A, Srivastava VK (1992) Salmonella typhi meningitis with facial nerve palsy. Indian Pediatr 29: 901–902.
- 34. Maheshwari VD, Jain MK, Karant VN (2001) Intracerebral haemorrhage as a complication of enteric fever. J Assoc Physicians India 49: 1035.
- 35. Gdynia HJ, Muller T, Sperfeld AD, Kuhnlein P, Otto M, et al. (2008) Severe sensorimotor neuropathy after intake of highest dosages of vitamin B6. Neuromuscul Disord 18: 156–158. doi: 10.1016/j.nmd.2007.09.009
- 36. Incecik F, Herguner MO, Altunbasak S, Leblebisatan G (2010) Neurologic findings of nutritional vitamin B12 deficiency in children. Turk J Pediatr 52: 17–21.
- 37. Mankad K, Kullmann DM, Davagnanam I (2010) Neurological manifestation of vitamin B12 deficiency. Am J Med 123: e1–2. doi: 10.1016/j.amjmed.2009.12.024
- 38. Senol MG, Sonmez G, Ozdag F, Saracoglu M (2008) Reversible myelopathy with vitamin B12 deficiency. Singapore Med J 49: e330–332.
- 39. Cliff J, Muquingue H, Nhassico D, Nzwalo H, Bradbury JH (2010) Konzo and continuing cyanide intoxication from cassava in Mozambique. Food Chem Toxicol doi: 10.1016/j.fct.2010.06.056
- 40. Cliff J, Nicala D (1997) Long-term follow-up of konzo patients. Trans R Soc Trop Med Hyg 91: 447–449. doi: 10.1016/s0035-9203(97)90279-0
- 41. Tylleskar T, Howlett WP, Rwiza HT, Aquilonius SM, Stalberg E, et al. (1993) Konzo: a distinct disease entity with selective upper motor neuron damage. J Neurol Neurosurg Psychiatry 56: 638–643. doi: 10.1136/jnnp.56.6.638
- 42. Njoh J (1990) Tropical ataxic neuropathy in Liberians. Trop Geogr Med 42: 92–94.
- 43. Madhusudanan M, Menon MK, Ummer K, Radhakrishnanan K (2008) Clinical and etiological profile of tropical ataxic neuropathy in Kerala, South India. Eur Neurol 60: 21–26. doi: 10.1159/000127975
- 44. Barceloux DG (2009) Grass pea and neurolathyrism (Lathyrus sativus L.). Dis Mon 55: 365–372. doi: 10.1016/j.disamonth.2009.03.006
- 45. Bradbury JH, Lambein F (2011) Konzo and neurolathyrism: similarities and dissimilarities between these crippling neurodegenerative diseases of the poor. Food Chem Toxicol 49: 537–538. doi: 10.1016/j.fct.2010.11.001
- 46. Henkel JS, Baldwin MR, Barbieri JT (2010) Toxins from bacteria. EXS 100: 1–29. doi: 10.1007/978-3-7643-8338-1_1
- 47. von Rhein C, Bauer S, Lopez Sanjurjo EJ, Benz R, Goebel W, et al. (2009) ClyA cytolysin from Salmonella: distribution within the genus, regulation of expression by SlyA, and pore-forming characteristics. Int J Med Microbiol 299: 21–35. doi: 10.1016/j.ijmm.2008.06.004
- 48. von Rhein C, Hunfeld KP, Ludwig A (2006) Serologic evidence for effective production of cytolysin A in Salmonella enterica serovars typhi and paratyphi A during human infection. Infect Immun 74: 6505–6508. doi: 10.1128/iai.00779-06
- 49. Kalita J, Srivastava R, Mishra MK, Basu A, Misra UK (2010) Cytokines and chemokines in viral encephalitis: a clinicoradiological correlation. Neurosci Lett 473: 48–51. doi: 10.1016/j.neulet.2010.02.017
- 50. Ichiyama T, Morishima T, Isumi H, Matsufuji H, Matsubara T, et al. (2004) Analysis of cytokine levels and NF-kappaB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy. Cytokine 27: 31–37. doi: 10.1016/j.cyto.2004.03.012
- 51. Ichiyama T, Isumi H, Ozawa H, Matsubara T, Morishima T, et al. (2003) Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy. Scand J Infect Dis 35: 59–61. doi: 10.1080/0036554021000026986